ATTENDS LIMITED

Company Registration Number:
03718732 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2024

Period of accounts

Start date: 1 January 2024

End date: 31 December 2024

ATTENDS LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2024

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

ATTENDS LIMITED

Directors' report period ended 31 December 2024

The directors present their report with the financial statements of the company for the period ended 31 December 2024

Principal activities of the company

The Company sells absorbent and other related adult incontinence products to the healthcare industry in the UK. There have been no changes in the Company's activities in the year under review.



Directors

The directors shown below have held office during the whole of the period from
1 January 2024 to 31 December 2024

Sarah Curtis
Emilio Barta


Secretary Alessandra Salvo

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
26 September 2025

And signed on behalf of the board by:
Name: Sarah Curtis
Status: Director

ATTENDS LIMITED

Profit And Loss Account

for the Period Ended 31 December 2024

2024 2023


£

£
Turnover: 35,947,908 31,287,954
Cost of sales: ( 30,109,314 ) ( 25,946,427 )
Gross profit(or loss): 5,838,594 5,341,527
Distribution costs: ( 4,848,009 ) ( 4,428,322 )
Administrative expenses: ( 459,964 ) ( 428,029 )
Operating profit(or loss): 530,621 485,176
Interest receivable and similar income: 321,849 68,412
Interest payable and similar charges: ( 1,784 )
Profit(or loss) before tax: 850,686 553,588
Tax: ( 215,937 )
Profit(or loss) for the financial year: 634,749 553,588

ATTENDS LIMITED

Balance sheet

As at 31 December 2024

Notes 2024 2023


£

£
Fixed assets
Tangible assets: 3 7,010 4,342
Total fixed assets: 7,010 4,342
Current assets
Stocks: 4 1,029,196 767,458
Debtors: 5 8,944,564 8,146,700
Cash at bank and in hand: 1,914,696 395,192
Total current assets: 11,888,456 9,309,350
Creditors: amounts falling due within one year: 6 ( 3,404,248 ) ( 1,457,223 )
Net current assets (liabilities): 8,484,208 7,852,127
Total assets less current liabilities: 8,491,218 7,856,469
Total net assets (liabilities): 8,491,218 7,856,469
Capital and reserves
Called up share capital: 1,000 1,000
Profit and loss account: 8,490,218 7,855,469
Total Shareholders' funds: 8,491,218 7,856,469

The notes form part of these financial statements

ATTENDS LIMITED

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 26 September 2025
and signed on behalf of the board by:

Name: Sarah Curtis
Status: Director

The notes form part of these financial statements

ATTENDS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Revenue is measured at the fair value of the consideration received or receivable and represents the amount receivable for goods supplied, net of returns, discounts and rebates allowed by the group and value added taxes. Revenue is recognised when the products are delivered to the customer and the control of the products has transferred to them.

    Tangible fixed assets depreciation policy

    Tangible fixed assets The carrying values of tangible fixed assets are reviewed for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable. Depreciation Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses. Depreciation is provided on all tangible fixed assets, at rates calculated to write-off the cost or valuation, less estimated residual value, of each asset evenly over its expected useful economic life, as follows: Computer systems 3 years Leasehold improvements 5 years Leasehold improvements in the course of construction are not amortised until brought into use.

    Other accounting policies

    Stocks Stock is valued at the lower of cost and fair value less costs to sell. Cost is based on the cost of purchase on a "first in, first out" basis. Fair value less costs to sell is based on estimated selling price less additional costs to completion and disposal. Share capital Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as deduction, net of tax, from proceeds Foreign currencies Transactions denominated in foreign currencies are recorded in Pounds, which is the functional currency, at the exchange rates ruling at the applicable date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated at the rate of exchange prevailing at the balance sheet date and any gain or loss reflected in the Profit and Loss Account. Leased assets Leases that do not transfer all the risks and rewards of ownership are classified as operating leases. Payments under operating leases are charged to the Profit and Loss Account on a straight-line basis over the period of the lease. Pension costs Contributions to the Company's defined contribution pension scheme are charged to the Profit and Loss Account in the period in which they become payable. Debtors Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment for bad or doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad or doubtful debts. Cash and cash equivalents Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature no more than three month from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value. Creditors Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. Financial instruments The Company has applied the Sections 11 and 12 of FRS 102 in respect of financial instruments. The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares. Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at the present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade payables or receivables, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like payment of a trade debt deferred beyond normal business terms or finance at a rate of interest that is not market rate or in case of an outright short term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost. Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If the objective evidence of impairment is found, an impairment loss is recognised in the Profit and Loss Account. For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset’s carrying amount and the present value of estimated cash flows discounted at the asset’s original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract. For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset’s carrying amount and best estimate of recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date. Financial assets and liabilities are offset and the net amount reported in the balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or realise the assets and settle the liability simultaneously. Provisions Provisions (i.e. liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably. Finance costs Finance costs of debt are recognised in the Profit and Loss Account over the term of such instruments at a constant rate. Finance costs include issue costs, which are initially recognised as a reduction in the proceeds of the associated capital instrument Going concern No significant going concern risk has been identified. The Company has a guaranteed profit margin through a Limited Risk Distribution transfer price agreement with the manufacturing company within the group. The parent company Journey Personal Care Holdings Ltd has confirmed that it will continue to provide financial support to the Company for the foreseeable future and for at least twelve months from the date of approval of these financial statements. Accordingly the financial statements have been prepared on the going concern basis. Journey Personal Care Holdings Ltd’s group cash flow forecast and projections, taking account of reasonably foreseeable changes in external factors and trading performance, show that the group should be able to operate within the level of its current facility and will be able to comply with future financial covenant obligations.

ATTENDS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 23 24

ATTENDS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 January 2024 56,778 87,292 144,070
Additions 5,800 5,800
Disposals ( 49,778 ) ( 76,000 ) ( 125,778 )
Revaluations
Transfers
At 31 December 2024 12,800 11,292 24,092
Depreciation
At 1 January 2024 53,395 86,333 139,728
Charge for year 2,173 959 3,132
On disposals ( 49,778 ) ( 76,000 ) ( 125,778 )
Other adjustments
At 31 December 2024 5,790 11,292 17,082
Net book value
At 31 December 2024 7,010 0 7,010
At 31 December 2023 3,383 959 4,342

ATTENDS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

4. Stocks

2024 2023
£ £
Stocks 1,029,196 767,458
Total 1,029,196 767,458

ATTENDS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

5. Debtors

2024 2023
£ £
Trade debtors 6,774,262 4,344,166
Other debtors 2,170,302 3,802,534
Total 8,944,564 8,146,700

ATTENDS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

6. Creditors: amounts falling due within one year note

2024 2023
£ £
Trade creditors 217,255 168,151
Taxation and social security 1,023,334 1,026,334
Accruals and deferred income 237,992 230,191
Other creditors 1,925,667 32,547
Total 3,404,248 1,457,223

ATTENDS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

7. Financial Commitments

At 31 December 2024, the Company had annual commitments under non-cancellable operating leases